BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22578373)

  • 21. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogen reduction technique for fresh-frozen plasma, cryoprecipitate, and plasma fraction minipools prepared in disposable processing bag systems.
    Burnouf T; Radosevich M; El-Ekiaby M; Goubran H
    Transfusion; 2011 Feb; 51(2):446-7; author reply 447-8. PubMed ID: 21309785
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evolution of the practices of labile blood product distribution].
    Tardivel R
    Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509
    [No Abstract]   [Full Text] [Related]  

  • 24. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.
    O'Mahony B; Turner A
    Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632
    [No Abstract]   [Full Text] [Related]  

  • 25. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multilayer-strategy to enhance optimal safety of the blood supply: The role of pathogen inactivation for optimizing recipient safety and helping health care cost containment: Moderator views.
    Seghatchian J
    Transfus Apher Sci; 2015 Apr; 52(2):233-6. PubMed ID: 25748230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 28. Military walking blood bank and the civilian blood service.
    Berséus O; Hervig T; Seghatchian J
    Transfus Apher Sci; 2012 Jun; 46(3):341-2. PubMed ID: 22475543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How we closed the gap between red blood cell utilization and whole blood collections in our institution.
    Marques MB; Polhill SR; Waldrum MR; Johnson JE; Timpa J; Patterson A; Salzman D
    Transfusion; 2012 Sep; 52(9):1857-67. PubMed ID: 22128835
    [No Abstract]   [Full Text] [Related]  

  • 30. Paediatric transfusion.
    New HV
    Vox Sang; 2006 Jan; 90(1):1-9. PubMed ID: 16359350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion of blood components to infants under four months: review and guidelines.
    O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
    Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfusion Solution.
    Haelle T
    Sci Am; 2015 Jul; 313(1):20. PubMed ID: 26204705
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evolution of neonatal transfusion practices: current recommendations].
    Plaisant F
    Transfus Clin Biol; 2011 Apr; 18(2):262-8. PubMed ID: 21440478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The computer or electronic crossmatch.
    Butch SH; Oberman HA
    Transfus Med Rev; 1997 Oct; 11(4):256-64. PubMed ID: 9345707
    [No Abstract]   [Full Text] [Related]  

  • 35. Improvement of national blood safety profile: effect of contract fractionation of plasma in resource limited countries, the Moroccan experience.
    Boulahdid S; Benahadi A; Adouani B; Laouina A; Mehdaoui FE; Mokhtari A; Soulaymani A; Hajjout K; Alami R
    Haemophilia; 2014 Sep; 20(5):e359-62. PubMed ID: 25039933
    [No Abstract]   [Full Text] [Related]  

  • 36. Trans people and blood donation.
    Goldman M; Butler-Foster T; Lapierre D; O'Brien SF; Devor A
    Transfusion; 2020 May; 60(5):1084-1092. PubMed ID: 32343438
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quality indicators and dashboards: the experience of a collection department].
    Danic B; Bécel C; Beauplet A
    Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of standard definitions for surveillance of complications related to blood donation.
    Goldman M; Land K; Robillard P; Wiersum-Osselton J
    Vox Sang; 2016 Feb; 110(2):185-8. PubMed ID: 26361365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical issues in neonatal transfusion practice.
    Strauss RG
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S57-63. PubMed ID: 9124231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.